# Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

> **NCT05183841** · NA · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Bronchiectasis Adult

## Interventions

- **DRUG:** Bronchodilator (Ipratropium and Fenoterol)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05183841
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-14
- **Primary completion:** 2024-11
- **Final completion:** 2025-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05183841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05183841, "Bronchodilators on the Exercise Capacity of Bronchiectasis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05183841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*